<i>Clostridium difficile </i>Infections: Epidemiology and Diagnostics

913

Use of a Standardized Infection Ratio (SIR) Model to Monitor a Nationwide Healthcare-Associated Clostridium difficile Prevention Initiative within the U.S. Department of Veterans Affairs (VA) Healthcare System
Stephen Kralovic, MD, MPH, FSHEA ; Martin Evans, MD, FIDSA, FSHEA ; Loretta Simbartl, MS ; Gary Roselle, MD, FIDSA

914

Prevalence, Hospital Length of Stay (LOS), and Costs of Clostridium difficile Infection (CDI) among Non-maternal Adult Hospital Discharges (NAHD) in the US, 2001-2012
Emelline Liu, MSHS ; Ruiqi Cen, MPH ; Qian Shi, MPH ; Michele Schoonmaker, PhD ; Lizheng Shi, PhD

915

Hospital Incidence of Clostridium difficile Infection (CDI) as a Risk Factor for Hospital-Associated CDI
Aaron Miller, PhD ; Linnea Polgreen, PhD ; Joseph Cavanaugh, PhD ; Philip M. Polgreen, MD

Posters

Presure_Paper_Poster2.pdf (677.6 kB)

916

Risk Factors for Community-Associated Clostridium Difficile Infection: a Case Control Study
Susan N. Hocevar, MD ; Sandra N. Bulens, MPH ; Monica Farley, MD, FIDSA ; Stacy Holzbauer, DVM, MPH, DACVPM ; Emily B. Hancock, MS ; Ghinwa Dumyati, MD, FSHEA ; Corinne M. Davis, MPH ; Carol Lyons, MPH ; Rebecca Perlmutter, MPH ; Erin Parker, MPH ; Claire Reisenauer, DVM ; Valerie L.S. Ocampo, RN, MIPH ; Yi Mu, PhD ; L. Clifford Mcdonald, MD, FSHEA

917

Independent Risk Factors for Recurrence of Clostridium difficile Infection: A Canadian Multicenter Prospective Cohort
Claire Nour Abou Chakra, MSc ; Allison Mcgeer, MD, MSc, FRCPC, FSHEA ; Annie-Claude Labbé, MD, FRCPC ; Andrew E. Simor, MD, FRCPC, FACP, FIDSA, FSHEA ; Wayne Gold, MD ; Matthew P. Muller, MD, PhD, FRCPC ; Jeff Powis, MD, MSc, FRCPC ; Kevin Katz, MD, CM, MSc, FRCPC ; Julian R. Garneau, BSc ; Louis-Charles Fortier, PhD ; Jacques Pepin, MD, MSc ; Louis Valiquette, MD, MSc

Posters

Poster IDweek2015- Risk factors for recurrence.pdf (612.7 kB)

918

Molecular and Clinical Epidemiology of Clostridium difficile Infection (CDI) in Three Diverse Medical Centers in New York
Marisa Montecalvo, MD ; Mini Kamboj, MD ; Donna Mckenna, ANP MS ; Jonathan Menz, MBA ; Liz Klimczak, RN MS ; Melody Zolendjeski, RN ; Guiqing Wang, MD, PhD ; Gary Wormser, MD, FIDSA

Posters

IDSAPoster10_01_2015PDF.pdf (412.1 kB)

919

Trends in the incidence of Clostridium difficile infections and NAP1/027 strain in the elderly population of Monroe County, NY
Ghinwa Dumyati, MD, FSHEA ; Jennifer Berry, MPH ; Rebecca Tsay, MPH, MLS ; Deborah Nelson, MSN, RN ; Anita Gellert, RN

Posters

poster IDweek 2015 final.pdf (138.9 kB)

920

Geographic Distribution of Clostridium difficile Infection Burden by Various Counties in Michigan
Babbaljeet Kaur, MD ; Paul Kilgore, MD, MPH ; Abdulbaset Salim, MD, MPH ; Elizabeth Waldman, MPH ; Gloria E. Pizzo, RN/BSN ; Harolyn Baker, MPH ; Jackie Rosenblatt, PhD ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Teena Chopra, MD, MPH

Posters

IDSA poster.pdf (491.1 kB)

921

Candida Co-infection among Adults with Clostridium difficile Infection in Metropolitan Atlanta, 2009„Ÿ2013
Snigdha Vallabhaneni, MD, MPH ; Olivia M. Almendares, MSPH ; Monica Farley, MD, FIDSA ; Jessica Reno, MPH ; Zirka Smith, MPH ; Betsy Stein, RN, BSN ; Shelley S. Magill, MD, PhD ; Rachel M. Smith, MD, MPH ; Angela Cleveland, MPH ; Fernanda C. Lessa, MD

Posters

15_259796-A_PTR_Vallabhaneni,S_IDWeek.pdf (131.1 kB)

922

Prevalence, Hospital Length of Stay (LOS), and Costs of Clostridium difficile Infection (CDI) among Maternal Adult Hospital Discharges (MAHD) in the US, 2001-2012
Emelline Liu, MSHS ; Ruiqi Cen, MPH ; Qian Shi, MPH ; Michele Schoonmaker, PhD ; Lizheng Shi, PhD

923

Consensus Definition of Clostridium Difficile Infections That Are Not Preventable by Antibiotic Stewardship Programs
Jessica Seidelman, M.D. ; Kristen V. Dicks, MD ; Sarah S. Lewis, MD MPH ; Michael J. Durkin, MD, MPH ; Arthur W. Baker, MD, MPH ; Rebekah W. Moehring, MD, MPH ; Deverick Anderson, MD, MPH, FIDSA, FSHEA ; Daniel J. Sexton, MD, FIDSA, FSHEA ; Luke F. Chen, MBBS, MPH, CIC, FRACP

924

Case Vignettes to Analyze Physician and Nurse Decision-making regarding Clostridium difficile Infection
Nasia Safdar, MD, PhD, FSHEA ; Rebekah Blakney, MS ; Robert Wigton, MD ; Eric Yanke, MD

925

Mixed infection as a cause of relapsing Clostridium difficile associated disease
Janet Sun, BS ; Tracy Mcmillen, BS ; N. Esther Babady, Ph.D ; Mini Kamboj, MD

Posters

Recurrent C. diff Poster 2.pdf (91.7 kB)

926

Clostridium Difficile incidence and severity in transitional Long Term Care Facility Patients with Fecal Management Systems
Catherine Edgell, BS ; Yazan Kherallah, BS ; Teena Chopra, MD, MPH

Posters

IDSA 2015 green 3.png (1.2 MB)

927

Harnessing granular data from comprehensive electronic medical records for prediction of recurrent Clostridium difficile infection – challenges and opportunities
Gabriel Escobar, MD ; Jennifer Baker, B.S. ; John Greene, M.A. ; Juan Carlos Laguardia, M.S. ; Nicole Cossrow, MPH, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA

Posters

927_IDWPOSTER.pdf (444.7 kB)

928

Relationship Between Continued Antibiotic Use and All-cause Mortality in Hospital-onset Clostridium difficile Associated Diarrhea
Bert K. Lopansri, MD ; Rajesh Mehta, R.Ph, MS ; Edward Stenehjem, MD MSc ; Kristin Dascomb, MD, PhD ; John Burke, MD, FIDSA, FSHEA

Posters

C diff all cause mortality.pdf (586.4 kB)

929

The role of Clostridium difficile infection in infancy as a risk factor of childhood atopy
Eell Ryoo, M.D. ; Yunna Gong, Medical student ; Hann Tchah, M.D.

930

Risk Factors and Epidemiology of Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients During the Peri-transplant Period
Sol Aldrete, MD ; Colleen Kraft, MD ; Matthew Magee, Ph.D. ; Austin Chan, MD ; Rachel Friedman-Moraco, MD

931

The Epidemiology of Clostridium difficile Infections among Oncology Patients
Yunyoung Gina Chang, M.P.H. ; Louise Dembry, MD, MS, MBA, FSHEA ; David Banach, M.D., M.P.H., M.S.

Posters

IDWeek - Poster V2.pdf (1.9 MB)

932

Risk Factors for Recurrent Clostridium difficile Infection among Allogenic Stem Cell Transplant Recipients
Marcela Ferrada, M.D. ; Ninet Sinaii, Ph.D., M.P.H. ; David K. Henderson, M.D. ; Tara N. Palmore, M.D.

933

Risk Factors for Clostridium difficile Infection Recurrence
Sujan C. Reddy, MD ; Alice Guh, MD, MPH ; Fernanda C. Lessa, MD ; Yi Mu, PhD ; Zintars G. Beldavs, MS ; Corinne M. Davis, MPH ; Ghinwa Dumyati, MD, FSHEA ; Stacy M. Holzbauer, DVM, MPH ; Helen L. Johnston, MPH ; Carol Lyons, MPH ; Erin C. Phipps, DVM, MPH ; Lucy E. Wilson, MD ; Lisa G. Winston, MD ; Dale N. Gerding, MD, FIDSA ; L. Clifford Mcdonald, MD, FSHEA ; Monica Farley, MD, FIDSA

Posters

CDI recurrence - IDWeek2015 poster.pdf (313.5 kB)

934

Clostridium difficile and Surgery: A multi-center observational evaluation
Mandelin Cooper, Pharm.D., BCPS ; John Hammer, MD ; Brent Morris, Pharm.D., M.B.A ; Gary Winfield, MD

Posters

934_IDWPOSTER.pdf (265.6 kB)

935

Serum Inflammatory Mediator Profiles Differentiate Patients with Complicated and Uncomplicated Clostridium difficile Infection
Krishna Rao, MD, MS ; Kavitha Santhosh, MD ; Jill Mogle, LPN ; Andrezj T. Galecki, MD, PhD ; Peter D. R. Higgins, MD, PhD ; Vincent B. Young, MD, PhD, FIDSA

Posters

Serum Inflammatory Mediator Profiles Differentiate Patients with Complicated and Uncomplicated Clostridium difficile Infection.pdf (918.0 kB)

936

Fecal Biomarkers of Clostridium Difficile (CD) Associated Disease (CDAD)
Xunyan Ye, PhD ; Meina Zhao, PhD ; Alejandro Restrepo, M.D. ; John Van, BA ; Todd M. Lasco, PhD ; Kevin W. Garey, PharmD, M.S. ; Herbert Dupont, MD, FIDSA ; Hoonmo L. Koo, MD, MPH

Posters

IDWeek 2015.pdf (111.3 kB)

937

Depressive Disorders, Antidepressant Use, and Alcohol Dependency in Persons with Community-Associated Clostridium difficile Infection, Minnesota 2013–2014
Tory Whitten, MPH ; Stacy Holzbauer, DVM, MPH, DACVPM

Posters

TW 2015 IDSA Draft 6.pdf (282.9 kB)

938

The Food of Hospitalized Patients as a Risk Factor for Acquisition of Clostridium difficile: A Modeling Study
Jennie H. Kwon, D.O. ; Cristina Lanzas, DVM, PhD ; Kimberly Reske, MPH ; Tiffany Hink, BS ; Sondra Seiler, BA ; Carey-Ann D. Burnham, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA

939

Home narcotic use and severity of CDI ?
Nongnooch Poowanawittayakom, MD

Posters

CDI_IDSA.jpg (685.2 kB)

940

Hospital Underutilization of Present on Admission Indicators for Hospital-Acquired Clostridium difficile Infection
Aaron Miller, PhD ; Linnea Polgreen, PhD ; Joseph Cavanaugh, PhD ; Philip M. Polgreen, MD

Posters

POA_PosterIDweek2.pdf (347.7 kB)

941

The effect of body mass index on the risk of Clostridium difficile infection in persons with inflammatory bowel disease
Amanda Thornton, MD ; Gregory Patts, MPH ; Janice Weinberg, ScD ; Nahid Bhadelia, MD, MA

942

Is Clostridium difficile Infection a Risk Factor for Subsequent Bloodstream Infection?
Robert J. Ulrich, MD ; Krishna Rao, MD, MS ; Kavitha Santhosh, MD ; Jill Mogle, LPN ; Vincent B. Young, MD, PhD, FIDSA

Posters

IDSAposter-FINAL.pdf (597.9 kB)

943

Bacteremia associated with Clostridium difficile colitis: Incidence, risk factors, and outcomes
Andrea Censullo, MD ; Jonathan Grein, MD ; Meghan Madhusudhan, MPH ; Rekha Murthy, MD, FIDSA, FSHEA

Posters

C difficile poster FINAL.pdf (897.9 kB)

944

Pseudo-Epidemic Clostridium difficile and Laxative Use
Sagar Batajoo, MD ; Jeanine Weber, RN ; Jaime Fried, BSN, RN ; Kelly Brady, NP ; Adam Baghban, MD ; Rebecca Schwartz, PhD ; Barbara Edwards, MD ; Bruce Hirsch, MD

Posters

944_IDWPOSTER.pdf (1.4 MB)

945

Characteristics of fecal microbiota in Korean patients with Clostridium difficile associated diarrhea
Hea Won Ann, MD ; Jin Young Ahn, MD ; Young Soun Lim, M.S ; Mi-Young Ahn, MD ; Yong Duk Jeon, MD ; In Young Jung, MD ; Nam Su Ku, MD ; Dongeun Yong, MD, PhD ; Kyungwon Lee, MD, PhD ; June Myung Kim, MD, PhD ; Jun Yong Choi, MD, PhD

946

Clinical Characteristics and Outcomes of Clostridium difficile Infection among Elderly Patients: A Multicenter Study in Japan
Mayu Hikone, M.D. ; Yusuke Ainoda, M.D., Ph.D. ; Kenichiro Kobayashi, M.D. ; Noritaka Sekiya, M.D. ; Hanako Kurai, M.D. ; Akifumi Imamura, M.D.

Posters

CDI in elderly_ID week poster?????ver2_PDF.pdf (1.9 MB)

948

Use of the Cepheid Xpert C.difficile/Epi Assay to Identify the Epidemic Strain of Clostridium difficile
Stanley Giddings, MD ; Michaela Gazdik, PHD ; John Burke, MD, FIDSA, FSHEA ; Bert K. Lopansri, MD

Posters

ID week C diff Xpert.pdf (596.3 kB)

949

The Significance and Utility of a Highly Sensitive PCR Test for the Diagnosis of Clostridium difficile Infection (CDI)
Becky Smith, MD ; Edward Schaefer, DO ; Emelline Liu, MSHS ; Michele Schoonmaker, PhD ; Jessica Ridgway, MD ; Ari Robicsek, MD ; Lance Peterson, MD, FIDSA, FSHEA

Posters

IDSA 2015 CDI poster final.pdf (565.5 kB)

950

Evaluation of the performance of the Target Enriched Multiplex Polymerase Chain Reaction (TEM-PCR) Gastrointestinal (GI) Panel vs the Cepheid Xpert C. difficile/Epi assay for the detection of toxigenic Clostridium difficile
Khushdeep Chahal, MD ; Esmeralda Gutierrez-Asis, MD ; Farrah Ibrahim, MD FACP ; Elena Grigorenko, PhD ; Stefan Brzezinski, MBA, BS ; Donald Stalons, PhD, D(ABMM), MPH ; Ali Hassoun, MD FIDSA FACP

951

Toxin Gene Nucleic Acid Amplification Test Cycle Threshold Result is Associated with Severity of C. difficile Infection and Poor Patient Outcomes
Kerrie Davies, MSc ; Timothy Planche, MD ; Nan Shetty, MD ; Mike Wren, PhD ; Derrick Crook, Professor ; Mark Wilcox, MD

Posters

poster for ID week 2015 1.3 250915.pdf (368.2 kB)

952

Detection of Clostridium difficile by Real-Time Polymerase Chain Reaction in Young Children Does Not Predict Diarrhea
Barbara Pahud, MD MPH ; Christopher Harrison, M.D., FSHEA, FPIDS ; Ferdaus Hassan, PhD ; Natasha Halasa, MD, MPH, FPIDS ; James D. Chappell, MD, PhD ; Janet Englund, MD, FIDSA ; Eileen Klein, MD, MPH ; Peter G Szilagyi, MD, MPH ; Geoffrey Weinberg, MD, FIDSA, FPIDS ; Christopher Polage, MD ; Mary E. Wikswo, MPH ; L. Clifford Mcdonald, MD, FSHEA ; Daniel Payne, PhD, MSPH ; Rangaraj Selvarangan, PhD

Posters

Pahud - IDSA C diff 10-4-15 FINAL.pdf (874.2 kB)

953

Relevance of Indeterminate Clostridium difficile (CD) Toxin Tests with positive CD PCR
Gordana Simeunovic, MD ; Riad Khatib, MD, FIDSA ; Mamta Sharma, MD, FIDSA

Posters

Gordana-CD-poster-IDSA rev 9-24-15 AM.pdf (390.2 kB)

954

In Vivo Correlation Between Clostridium difficile Toxin and Spore levels in Symptomatic CDI Patients
Natalia Blanco, MPH ; Anurag Malani, MD, FIDSA ; Marisa Eisenberg, PhD, MS ; Alexander Rickard, PhD, MSc, BSc ; Seth Walk, PhD ; Betsy Foxman, PhD, FIDSA

Posters

IDweek_Poster1004.pdf (572.6 kB)

955

Laxative Use and Testing Delays May Overestimate the True Burden of C. difficile
Stephen Rineer, BS ; Justin Dizon, BS ; Julia Logan, PharmD ; Vincent Hsu, MD MPH FACP

Posters

Rineer C difficille -IDWeek Poster (Rineer1).pdf (366.3 kB)

Navigation

Browse by Day:

Browse by Track: